126 related articles for article (PubMed ID: 37178520)
21. The roles of Y-box-binding protein (YB)-1 and C-X-C motif chemokine ligand 14 (CXCL14) in the progression of prostate cancer via extracellular-signal-regulated kinase (ERK) signaling.
Wang C; Zhao N; Sato F; Tanimoto K; Okada H; Liu Y; Bhawal UK
Bioengineered; 2021 Dec; 12(2):9128-9139. PubMed ID: 34696665
[TBL] [Abstract][Full Text] [Related]
22. CXCL14 Overexpression Attenuates Sepsis-Associated Acute Kidney Injury by Inhibiting Proinflammatory Cytokine Production.
Lv J; Wu ZL; Gan Z; Gui P; Yao SL
Mediators Inflamm; 2020; 2020():2431705. PubMed ID: 32317861
[TBL] [Abstract][Full Text] [Related]
23. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.
Augsten M; Hägglöf C; Olsson E; Stolz C; Tsagozis P; Levchenko T; Frederick MJ; Borg A; Micke P; Egevad L; Ostman A
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3414-9. PubMed ID: 19218429
[TBL] [Abstract][Full Text] [Related]
24. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.
Augsten M; Sjöberg E; Frings O; Vorrink SU; Frijhoff J; Olsson E; Borg Å; Östman A
Cancer Res; 2014 Jun; 74(11):2999-3010. PubMed ID: 24710408
[TBL] [Abstract][Full Text] [Related]
25. PKCα in colon cancer cells promotes M1 macrophage polarization via MKK3/6-P38 MAPK pathway.
Cheng Y; Zhu Y; Xu W; Xu J; Yang M; Chen P; Zhao J; Geng L; Gong S
Mol Carcinog; 2018 Aug; 57(8):1017-1029. PubMed ID: 29637628
[TBL] [Abstract][Full Text] [Related]
26. CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8
Westrich JA; Vermeer DW; Silva A; Bonney S; Berger JN; Cicchini L; Greer RO; Song JI; Raben D; Slansky JE; Lee JH; Spanos WC; Pyeon D
Oncogene; 2019 Nov; 38(46):7166-7180. PubMed ID: 31417179
[TBL] [Abstract][Full Text] [Related]
27. Polymersomes-Mediated Delivery of CSF1R Inhibitor to Tumor Associated Macrophages Promotes M2 to M1-Like Macrophage Repolarization.
Rodriguez-Perdigon M; Jimaja S; Haeni L; Bruns N; Rothen-Rutishauser B; Rüegg C
Macromol Biosci; 2022 Aug; 22(8):e2200168. PubMed ID: 35624036
[TBL] [Abstract][Full Text] [Related]
28. CXCL14, a Brown Adipokine that Mediates Brown-Fat-to-Macrophage Communication in Thermogenic Adaptation.
Cereijo R; Gavaldà-Navarro A; Cairó M; Quesada-López T; Villarroya J; Morón-Ros S; Sánchez-Infantes D; Peyrou M; Iglesias R; Mampel T; Turatsinze JV; Eizirik DL; Giralt M; Villarroya F
Cell Metab; 2018 Nov; 28(5):750-763.e6. PubMed ID: 30122557
[TBL] [Abstract][Full Text] [Related]
29. CXCL14 inhibits the growth and promotes apoptosis of hepatocellular carcinoma cells via suppressing Akt/mTOR pathway.
Bi J; Liu Q; Sun Y; Hu X; He X; Xu C
J Recept Signal Transduct Res; 2021 Dec; 41(6):593-603. PubMed ID: 33108937
[TBL] [Abstract][Full Text] [Related]
30. S100A9 promotes tumor-associated macrophage for M2 macrophage polarization to drive human liver cancer progression: An in vitro study.
Yang LF; Zhang ZB; Wang L
Kaohsiung J Med Sci; 2023 Apr; 39(4):345-353. PubMed ID: 36807724
[TBL] [Abstract][Full Text] [Related]
31. Antibody-assisted enhancement of biological activities of CXCL14 in human monocytic leukemia-derived THP-1 cells and high fat diet-induced obese mice.
Tanegashima K; Suzuki K; Nakayama Y; Hara T
Exp Cell Res; 2010 Apr; 316(7):1263-70. PubMed ID: 20083103
[TBL] [Abstract][Full Text] [Related]
32. Upregulated CXCL14 is associated with poor survival outcomes and promotes ovarian cancer cells proliferation.
Li X; Zhao L; Meng T
Cell Biochem Funct; 2020 Jul; 38(5):613-620. PubMed ID: 32077118
[TBL] [Abstract][Full Text] [Related]
33. Acute Lymphoblastic Leukaemia Cells Impair Dendritic Cell and Macrophage Differentiation: Role of BMP4.
Valencia J; M Fernández-Sevilla L; Fraile-Ramos A; Sacedón R; Jiménez E; Vicente A; Varas A
Cells; 2019 Jul; 8(7):. PubMed ID: 31337120
[TBL] [Abstract][Full Text] [Related]
34. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
35. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
Shurin GV; Ferris RL; Tourkova IL; Perez L; Lokshin A; Balkir L; Collins B; Chatta GS; Shurin MR
J Immunol; 2005 May; 174(9):5490-8. PubMed ID: 15843547
[TBL] [Abstract][Full Text] [Related]
36. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
[TBL] [Abstract][Full Text] [Related]
37. Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma.
Parikh A; Shin J; Faquin W; Lin DT; Tirosh I; Sunwoo JB; Puram SV
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958684
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma.
Wei ST; Chiang JY; Wang HL; Lei FJ; Huang YC; Wang CC; Cho DY; Hsieh CH
Cancer Sci; 2023 Jan; 114(1):174-186. PubMed ID: 36106406
[TBL] [Abstract][Full Text] [Related]
39. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
40. CXCL14 and insulin action.
Hara T; Nakayama Y
Vitam Horm; 2009; 80():107-23. PubMed ID: 19251036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
